ArticleJACS Au2026
Catalytic Asymmetric Dearomative Cyclizations of Indolyldimethanols via Umpolung Strategy.
Article in JACS Au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The catalytic asymmetric dearomative (CADA) cyclization of indolylmethanols has been achieved via an umpolung strategy. By leveraging C3 umpolung of indolyldimethanols, two CADA cyclizations were realized under asymmetric organocatalysis. These transformations deliver two series of chiral indolenine- or indoline-based polycyclic scaffolds containing two or three adjacent stereogenic centers with high regio-, diastereo-, and enantioselectivity. This work not only provides a practical solution to persistent challenges in the CADA cyclization of indoles and introduces a C3 electrophilicity-based strategy for indole dearomatization, but also offers an efficient and stereoselective route to chiral indolenine- and indoline-fused polycyclic systems. Furthermore, mechanistic insights derived from theoretical calculations elucidate the plausible reaction pathway and account for the high regio- and stereoselectivity observed in the CADA cyclization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.